Long-term risk of neoplastic events after childhood growth hormone treatment: a population-based cohort study in Sweden.

For duration of treatment, there was a significant trend over duration categories (p trend =0.03) with the highest adjusted HRs in the group with the longest (≥7 years) treatment duration but only reaching significance in the restricted model and not in the full model (restricted model: HR 1.29, 95% CI: 1.03-1.61; full model: HR 1.23, 95% CI: 0.97-1.55, Table 3 ).

also in 9,775 other papers